SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Warrant Exercise

26 Nov 2021 07:00

RNS Number : 6622T
Sabien Technology Group PLC
26 November 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 November 2021

Sabien Technology Group plc

("Sabien" or the "Company")

Warrant Exercise Notice and Total Voting Rights

Sabien Technology Group plc, a company focussed on building a portfolio of operations which, in combination, provide critical elements of the transition to a Green Economy, announces that it has received an exercise notice from investors in relation to 50,000 warrants.

The Company announced the issue of the warrants on 20 January 2021, which are exercisable at an exercise price of 30 pence per share following the 29 March 2021 300:1 share consolidation. Accordingly, pursuant to the warrant exercise notice, Sabien will issue 50,000 new ordinary shares of 3 pence each in the capital of the Company ("Ordinary Shares") (the "New Shares"). Application will be made for the New Shares to be admitted to trading on AIM and admission is expected to become effective on 2 December 2021 ("Admission"). 

Following Admission, the Company will have 14,720,168 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any Ordinary Shares in Treasury. Following Admission, the figure of 14,720,168 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

+44 20 3328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 20 7469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien-tech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFESFUIEFSELF
Date   Source Headline
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.